Measures of disease and effects of treatment

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/40

encourage image

There's no tags or description

Looks like no tags are added yet.

41 Terms

1
New cards

The study of the use of and the effects of drugs in large numbers of people

Pharmacoepidemiology

2
New cards

the study of the effect of Rx (medications)

pharmacology

3
New cards

is the study of the distribution and determinants of disease in the population

epidemiology

4
New cards

Why is Pharmacoepi Important?

-population aging

-disease management

-more drugs

-inadequacy of systems

-growing emphasis on patient safety

-regulation and accreditation

-managed care

5
New cards

• Pharmacoepidemiology studies:

- Quantify drug use patterns

- Quantify adverse drug effects

6
New cards

Evaluate acute and short-term toxicity in animals:

• Dose at increasingly high levels to induce toxicity • Determine the lethal dose • Dose at normal levels for short and long term

Pre-clinical

7
New cards

Assess how the drug is absorbed, distributed, metabolized, and excreted in animals

pre-clinical

8
New cards

How long is pre-clinical?

3-6 years

9
New cards

Measurable Drug Effects:

-Anticipated beneficial effects

--Efficacy versus effectiveness

-Unanticipated beneficial effects

-Unanticipated harmful effects

-Anticipated harmful effects

10
New cards

-Determine saf and dosage

phase 1

11
New cards

Evaluate efficacy and side effects

phase 2

12
New cards

Verify efficacy

phase 3

13
New cards

How Do We Fill in These Gaps?

Pharmacoepidemiology

o Phase IV research

Benefits and Risks

o PharmEpi Research

o Pharmacovigilance / Surveillance

o Safety / Risk Management

14
New cards

frequency an event occurs in a population at risk during a specified time

rates

15
New cards

numerator and denominator always related and expressed as a percentage

proportions

16
New cards

Rates:

number of events/population at risk

17
New cards

q Popular measures for quantifying morbidity at population level are:

incidence

prevalence

18
New cards

Number of new cases that occurs [numerator] in a population at risk for developing the disease [denominator] during a specified time period ( annually)

incidence

19
New cards

Measures the rapidity with which a new condition develops in a populations (growth or flow)

incidence

20
New cards

Useful for studying the cause of disease and evaluating effectiveness of programs to prevent disease from developing

incidence

21
New cards

is the number of new cases over a specified time period divided by the size of the population initially at risk.

cumulative incidence

22
New cards

This is used when the at-risk population observed is constant during the period of measurement

cumulative incidence

23
New cards

Cumulative incidence equation:

number of new cases of disease during period / number at risk during a period

24
New cards

q Number of new cases per population at risk in a given time period

incidence rate

25
New cards

o Study population is dynamic

incidence rate

26
New cards

o Measures how fast new cases of a disease occur (rapidity of new cases of an event)

incidence rate

27
New cards

Incidence rate:

number of new cases/total person time

28
New cards

Measures the number of new cases of disease during a specified period of time as a proportion of the total time at which individuals in a population at risk are observed

incidence rate

29
New cards

the snapshot of health-related (old and new) cases in a population at a particular point or period in time.

prevalence

30
New cards

The number of named disease or drug related cases ( old and new) at a point or period in time

prevalence

31
New cards

Range of measure for prevalence:

0 to 1

32
New cards

is the number of persons with disease in a time interval (eg, one year) divided by number of persons in the population; that is, prevalence at the beginning of an interval plus any incident cases.

point prevalence

33
New cards

The calculation of _____ is based on a single examination at one point in time (snapshot in time)

point prevalence

34
New cards

point prevalence equation:

Number of persons with the case at a specified time/ number in the population at that time

35
New cards

Tells us how much of a disease is present in a population over a period of time

period prevalence

36
New cards

A condition with high incidence and long duration will have high what?

prevalence

37
New cards

CMR equation:

total number of deaths during year/ number of people in population during year

38
New cards

q Total number of deaths from all causes among individuals in a specific age category

Age-specific mortality rate

39
New cards

q Total number of deaths from a specific cause during a specific time period

Cause specific mortality rate

40
New cards

Limitation of cause specific mortality

q Limitation - miscoded or misclassified

41
New cards

cause-specific mortality rate equation:

(number of deaths due to a particular cause during a specified period) / the population during that period) x 1,000